Abdul Hameed Shoman foundation MS Reward
Title of presentation: Management of Acute Achilles rupture in the Elite Athletes
Event date: November 17-19, 2023
Event venue: Abu Dhabi National Exhibition Centre (ADNEC) Abu Dhabi – UAE
Nipah virus (NiV) is a zoonotic virus (it is transmitted from animals to humans) and can also be transmitted through contaminated food or directly between people.
The name, Nipah, is derived from the village in Malaysia where the person from whom the virus was first isolated succumbed to the disease. The Nipah virus was first recognized in 1999 during an outbreak among pig farmers in, Malaysia.
Fruit bats, also known as ‘flying foxes,’ of the genus Pteropus are the natural hosts for Nipah virus. The virus is present in bat urine and potentially, bat feces, saliva, and birthing fluids.
Although Nipah virus has cause only a few known outbreaks, it infects a wide range of animals and causes severe disease and death in people, making it a public health concern. The case fatality rate is estimated at 40% to 75%.
Symptoms typically appear in 4-14 days following exposure to the virus. The latest incubation period is 7 – 40 days.
Symptoms may initially include one or several of the following:
Severe symptoms may follow, such as:
In the first known NiV outbreak, people were probably infected through close contact with infected pigs. Transmission is thought to have occurred via unprotected exposure to secretions from the pigs, or unprotected contact with the tissue of a sick animal.
Animal-Human Transmission
Nipah virus (NiV) can spread to people from contact with infected animals, such as bats or pigs, or their body fluids (such as blood, urine or saliva).
Food-Human Transmission
Consuming food products that have been contaminated by body fluids of infected animals (such as palm sap or fruit contaminated by an infected bat).
Human-Human Transmission
Close contact with a person infected with NiV or their body fluids (including nasal or respiratory droplets, urine, or blood).
Currently there are no licensed treatments available for Nipah virus (NiV) infection. Treatment is limited to supportive care, including:
Intensive supportive care is recommended to treat severe respiratory and neurologic complications. Consult your Doctor for prescription of medication.
Initial signs and symptoms of Nipah virus infection are nonspecific, and the diagnosis is often not suspected at the time of presentation. The main tests used are real time polymerase chain reaction (RT-PCR) using the following bodily fluids to diagnose the condition:
Nipah virus (NiV) infection can be diagnosed during illness or after recovery.
In areas where Nipah virus (NiV) outbreaks have occurred (Bangladesh, Malaysia, India, and Singapore), people should:
Category | Discerption | Action |
---|---|---|
High Risk Exposure |
|
Asymptomatic: Home quarantine with active follow up for fever by healthcare workers, twice a day for 21 days Symptomatic: (fever)- Immediate admission in designated isolation ward with ICU facility |
Low Risk Exposure |
|
Asymptomatic: Home quarantine and follow up for fever by telephone. Symptomatic: (fever) Immediate admission in designated isolation facility |
“This article is just for educational purposes only”
Between 12 and 15 September 2023, a total of six laboratory-confirmed cases of Nipah virus infection including two deaths were reported by the State Government of Kerala. All confirmed cases were males within the age range of 9 to 45 years old and were reported within the Kozhikode district of Kerala.
Source: WHO: Nipah virus Infection 2023 outbreak – Kerala India
Title of presentation: Lisfranc’s injury, fixation vs. fusion
Event date: September 15-17, 2023
Event venue: Conrad Dubai, UAE
Can Natural Remedies Cure MS? Find Out In Episode 6 Of MS Talks 2.0
MS Talks 2.0 is a collaboration between Lovin Dubai and Novartis. The 10-episode series brings together experts and members of the community to bring awareness to Multiple Sclerosis.
Source: Lovin Dubai
Title of presentation: Ankle ligament injuries in sport
Event date: 13th and 14th May 2023
Event venue: Mohammed Bin Rashid University Of Medicine And Health Sciences (MBRU), Dubai
Loud beeping alarms, sunrise light, or scent – what is the best way to wake up?
Abu Dhabi: Dawn simulation or sunrise alarms have benefits for alertness, mood, cardiovascular stress.
Source: Gulf News
Adenovirus infections, though common, can prove serious for children, high-risk groups
Abu Dhabi: Respiratory infections are common with the changing weather, and the UAE has seen a spate of them since the current flu season kicked off in September 2022.
Source: Gulf News
Event name: McDonald Diagnostic Criteria Review 2023 – An initiative of the International Advisory Committee on Clinical Trials in MS
Event date: Nov 29 – Dec 2, 2023
Event venue: Sofitel Skipper, Barcelona, Spain
Event name: Multiple Sclerosis acadeMe: Shifting the Mindset, Reshaping the Future of MS
Event date: November 25, 2023
Event venue: Zurich, Switzerland
Event name: The 7th MENACTRIMS Congress is accredited for 19.0 CME hours by the American Association of Continuing Medical Education (AACEME)
Event date: 11 – 12 November, 2022
Event venue: InterContinental Citystars Cairo, Egypt
Professor Bassem Yamout with Professor Giancarlo Comi and Professor Tjalf Ziemssen along with students from the Charcot Multiple Sclerosis Master of Science program in cooperation with Dresden International University.
Event name: The launch of the “National Multiple Sclerosis Society”
Committee Members Prof. Bassem Yammout & Joelle Massouh from HSMC in attendance.
Event name: Less is More in MS management hosted by the Romanian Society of Neurology
Title of presentation: Long-term Management with Immune Reconstitution Therapies: Managing Disease Activity with Mavenclad
Event date: 4th March 2023
Event venue: Bucharest, Romania
Event name: 5th MS Summit jointly hosted by the European Society of Neuroradiology (ESNR) and the Egyptian MS Society
Title of presentation: EBV and Multiple Sclerosis: Are We Close to a Cure?
Event date: 2nd and 3rd March 2023
Event venue: Cairo Marriott Hotel, Zamalek, Egypt
Event date: 6th and 7th December 2019
Event venue: Intercontinental Dubai Festival City, Dubai, United Arab Emirates
Through hard work, persistence, and dedication in offering the highest levels of safe and effective care to our patients, we are honored to have earned Joint Commission International’s Gold Seal of Approval®
JCI is an affiliate of the most trusted name in accreditation – The Joint Commission. JCI is the recognized global leader in healthcare accreditation. The accreditation and certification from JCI is recognised as the Gold Seal of Approval® for international quality standards for patient care and organisation management. Their standards represent a worldwide consensus on quality patient care that reflects state-of-the-art healthcare practices and healthcare delivery trends.
In giving due recognition to organisations that comply with international healthcare quality standards, the JCI achieves its objective of helping organisations strive to attain the highest performance possible, improving patient outcomes, and creating an environment for continuous improvement. JCI is dedicated to continuously improving the safety and quality of care in the international community through the provision of education and advisory services and international accreditation and certification.
Click Here to go to JCI’s website.